Christopher Hite sold $8.2M of Royalty Pharma plc (RPRX) stock

Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 150,000 shares of RPRX stock worth $8.2M, per an SEC Form 4 filed Jun 25, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 23, 2026, 2 days before it was made public.

RPRX has moved +5.7% since the trade date, from $55.35 to $58.52 (Sep 22, 2026 close).